| |
| |
|
| Insider
Information: |
Smith Ian F |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
267,823 |
|
|
Indirect Shares
|
5,306 |
|
|
| Direct
Value |
$19,764,131 |
|
|
|
Indirect Value
|
$2,133,755 |
|
|
| Total
Shares |
273,129 |
|
|
| Total
Value |
$21,897,886 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2018-06-29 |
46,699 |
2018-06-29 |
5,306 |
Premium* |
|
|
Acorda Therapeutics Inc |
ACOR |
Director |
2018-06-15 |
0 |
2016-01-04 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2018-06-12 |
45,845 |
2017-05-25 |
0 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
|
2024-04-03 |
103,207 |
2020-12-10 |
0 |
Premium* |
|
|
Foghorn Therapeutics Inc. |
FHTX |
|
2021-04-27 |
72,072 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLDB |
Solid Biosciences Inc |
|
– • – |
2024-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,256 |
103,207 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
|
– • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,570 |
99,948 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
|
– • – |
2023-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,569 |
84,378 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
|
– • – |
2023-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,570 |
68,809 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2023-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,569 |
53,239 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,620 |
37,670 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2022-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,172 |
356,380 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2022-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,312 |
343,208 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2022-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,313 |
318,896 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2022-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,313 |
294,583 |
0 |
- |
|
| FHTX |
Foghorn Therapeutics Inc. |
|
– • – |
2021-04-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
72,072 |
|
- |
|
| SLDB |
Solid Biosciences Inc |
Director |
– • – |
2020-12-10 |
4 |
A |
$3.70 |
$999,999 |
D/D |
270,270 |
270,270 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-06-29 |
4 |
AS |
$165.22 |
$3,887,173 |
D/D |
(23,375) |
46,699 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-06-29 |
4 |
OE |
$131.89 |
$3,082,929 |
D/D |
23,375 |
70,074 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-06-22 |
4 |
AS |
$160.00 |
$680,000 |
D/D |
(4,250) |
46,699 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-06-22 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
50,949 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2018-06-15 |
4 |
OE |
$13.80 |
$461,500 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2018-06-15 |
4 |
AS |
$31.42 |
$785,568 |
D/D |
(25,000) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Director |
– • – |
2018-06-12 |
4 |
A |
$1.75 |
$40,000 |
D/D |
22,857 |
45,845 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-05-15 |
4 |
AS |
$155.78 |
$33,804 |
D/D |
(217) |
46,699 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-05-11 |
4 |
AS |
$155.00 |
$634,880 |
D/D |
(4,096) |
46,699 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-05-11 |
4 |
OE |
$86.52 |
$364,148 |
D/D |
4,096 |
50,795 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2018-05-02 |
4 |
AS |
$23.46 |
$237,175 |
D/D |
(10,000) |
0 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2018-05-02 |
4 |
OE |
$20.16 |
$201,600 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-04-26 |
4 |
AS |
$160.12 |
$8,506,375 |
D/D |
(53,125) |
46,699 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
